Tilray Inc (TLRY) - Cash Flow Conversion Efficiency

Latest as of February 2026: -0.015x

Based on the latest financial reports, Tilray Inc (TLRY) has a cash flow conversion efficiency ratio of -0.015x as of February 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-22.15 Million) by net assets ($1.53 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Tilray Inc to measure how much of total assets are equity-financed.

Tilray Inc - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Tilray Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Tilray Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Tilray Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tilray Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Zhejiang Tianzhen Technology Co. Ltd. A
SHE:301356
N/A
AMERISAFE Inc
NASDAQ:AMSF
-0.011x
Hangzhou Heshun Technology Co.LTD.
SHE:301237
N/A
Greenlight Capital Re Ltd
NASDAQ:GLRE
0.050x
Sariguna Primatirta PT
JK:CLEO
0.079x
Cimentas Izmir Cimento Fabrikasi TAS
IS:CMENT
0.007x
Guangzhou Grandbuy Co Ltd
SHE:002187
0.021x
Zhejiang Meishuo Electric Technology Co. Ltd. A
SHE:301295
N/A

Annual Cash Flow Conversion Efficiency for Tilray Inc (2012–2025)

The table below shows the annual cash flow conversion efficiency of Tilray Inc from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Tilray Inc.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-05-31 $2.04 Billion $-129.81 Million -0.064x -607.55%
2024-05-31 $4.69 Billion $-42.11 Million -0.009x -609.22%
2023-05-31 $4.49 Billion $7.91 Million 0.002x +105.57%
2022-05-31 $5.60 Billion $-177.26 Million -0.032x -161.85%
2021-05-31 $4.47 Billion $-53.99 Million -0.012x +98.66%
2020-05-31 $380.01 Million $-343.77 Million -0.905x -286.62%
2019-05-31 $269.10 Million $-62.97 Million -0.234x -118.91%
2018-05-31 $-6.17 Million $-7.63 Million 1.237x +194.26%
2017-05-31 $3.42 Million $-4.48 Million -1.313x -4550.71%
2016-05-31 $26.85 Million $-757.62K -0.028x +93.08%
2015-05-31 $10.74 Million $-4.38 Million -0.408x -169.35%
2014-05-31 $271.84K $-41.16K -0.151x 0.00%
2013-05-31 $271.84K $-41.16K -0.151x -17.18%
2012-05-31 $333.15K $-43.05K -0.129x --

About Tilray Inc

NASDAQ:TLRY USA Drug Manufacturers - Specialty & Generic
Market Cap
$543.00 Million
Market Cap Rank
#11619 Global
#2957 in USA
Share Price
$4.54
Change (1 day)
+8.10%
52-Week Range
$0.61 - $13.94
All Time High
$214.06
About

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and… Read more